Actively Recruiting
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
Led by Barbara Ann Karmanos Cancer Institute · Updated on 2025-09-18
30
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if tattoos applied with Magic Ink is as safe as commercially available standard tattoo ink for the purpose of radiation in women with breast cancer undergoing radiation treatment. The main questions are: * Is the Magic Ink as safe as standard tattoo ink * Does Magic Ink continue to function and remain visible for radiation therapists during the treatment Participants will be consented and given a skin assessment. Once enrolled participants will be administered the Magic Ink tattoo instead of the standard tattoo ink in preparation for their radiation treatment. Participants will also complete a survey regarding body image. Skin assessment will occur again after the first week of radiation and at 3 months later. Throughout the radiation therapy the medical physicist will complete surveys about ease of set-up of the equipment.
CONDITIONS
Official Title
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically or cytologically confirmed stage 0 ductal carcinoma in situ (DCIS), I, II, or III breast cancer
- Planning to undergo radiation therapy after surgery
- 18 years of age or older
- Able to understand and willing to sign informed consent
- Assigned female at birth
- Karnofsky performance score of 70% or higher
- Women of childbearing potential must agree to avoid pregnancy during radiation therapy and meet at least one of the following:
- Surgically sterile (hysterectomy, bilateral oophorectomy, or bilateral salpingectomy)
- Post-menopausal (no menses for at least 12 months without other cause)
- Agree to practice true abstinence from sexual intercourse
- Not in a sexual relationship where pregnancy is possible
- Use at least one highly effective and one additional method of contraception
- For the first six participants only: Fitzpatrick Skin Tone Scale of 5 or 6
You will not qualify if you...
- Prior radiation treatment to the affected breast
- History of allergic reaction or hypersensitivity to any tattoo ink
- Active chronic skin diseases such as psoriasis (inactive or controlled skin diseases allowed)
- Pregnant or breastfeeding (breastfeeding must be discontinued to participate)
- Body mass index (BMI) greater than 44.5 within six months before the study start
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Karmanos Cancer Institute
Detroit, Michigan, United States, 48201
Actively Recruiting
Research Team
M
Michael Dominello, DO
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here